HROW
Harrow Health, Inc. NASDAQ Listed Sep 28, 2007$39.05
Mkt Cap $1.5B
52w Low $21.12
53.2% of range
52w High $54.85
50d MA $38.57
200d MA $41.41
P/E (TTM)
-292.1x
EV/EBITDA
35.3x
P/B
28.9x
Debt/Equity
4.8x
ROE
-9.8%
P/FCF
41.9x
RSI (14)
—
ATR (14)
—
Beta
0.31
50d MA
$38.57
200d MA
$41.41
Avg Volume
716.4K
Harrow Health, Inc. operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business; and DEXYCU for the treatment of post-operative inflammation. The company also holds equity interests in Surface Ophthalmics, Inc., a clinical-stage pharmaceutical company that focuses on development and commercialization of therapeutics for ocular surface diseases; Melt Pharmaceuticals, Inc., a clinical-stage pharmaceutical company that focused on the development and commercialization of proprietary non-intravenous, sedation, and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings; and Eton Pharmaceuticals, Inc., a commercial-stage pharmaceutical company that engages in developing and commercializing drug products. Harrow Health, Inc. owns royalty rights in four clinical stage drug candidates being developed by Surface Ophthalmics, Inc. and Melt Pharmaceuticals, Inc. The company was formerly known as Imprimis Pharmaceuticals, Inc. and changed its name to Harrow Health, Inc. in December 2018. Harrow Health, Inc. was incorporated in 2006 and is headquartered in San Diego, California.
102 Woodmont Boulevard · Nashville, TN 37205 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 2, 2026 | AMC | 0.40 | 0.26 | -35.0% | 53.59 | -16.7% | -28.0% | -26.8% | -32.5% | -32.2% | -34.4% | — |
| Nov 10, 2025 | AMC | 0.22 | 0.33 | +50.0% | 34.14 | -0.4% | +13.5% | +12.6% | +11.0% | +19.5% | +18.0% | — |
| Aug 11, 2025 | AMC | 0.31 | 0.24 | -23.4% | 33.74 | +6.7% | +3.2% | +8.2% | +18.6% | +15.1% | +13.6% | — |
| May 8, 2025 | AMC | 0.02 | -0.38 | -2000.0% | 23.59 | -8.9% | +3.4% | +13.0% | +11.4% | +6.5% | +8.6% | — |
| Mar 27, 2025 | AMC | 0.11 | 0.25 | +127.3% | 27.87 | +8.3% | -6.0% | -4.6% | -10.4% | -6.5% | -13.7% | — |
| Nov 13, 2024 | AMC | -0.05 | -0.12 | -140.0% | 51.80 | -19.4% | -17.3% | -24.7% | -26.7% | -23.4% | -18.1% | — |
| Aug 7, 2024 | AMC | -0.25 | -0.13 | +48.0% | 21.98 | +43.2% | +54.3% | +63.5% | +61.5% | +72.2% | +68.6% | — |
| May 13, 2024 | AMC | -0.25 | -0.28 | -12.0% | 12.07 | +20.5% | +34.5% | +32.0% | +33.9% | +38.9% | +39.1% | — |
| Mar 19, 2024 | AMC | -0.05 | -0.27 | -455.6% | 10.65 | -11.5% | -1.2% | -0.7% | +8.0% | +12.7% | +18.1% | — |
| Nov 13, 2023 | AMC | -0.02 | -0.09 | -467.5% | 12.83 | -24.4% | -36.0% | -36.9% | -33.0% | -30.2% | -26.3% | — |
| Aug 9, 2023 | AMC | -0.01 | -0.02 | -250.4% | 19.80 | +1.3% | -15.5% | -14.5% | -12.7% | -13.2% | -14.1% | — |
| May 11, 2023 | AMC | -0.06 | -0.03 | +50.0% | 27.07 | -8.8% | -18.6% | -22.8% | -22.3% | -20.2% | -22.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 17 | BTIG | Maintains | Buy → Buy | — | $40.65 | $41.16 | +1.3% | +2.1% | -0.4% | -3.0% | -3.7% | -4.7% |
| Apr 7 | B. Riley Securities | Maintains | Buy → Buy | — | $35.13 | $34.51 | -1.8% | +0.9% | +4.6% | +6.1% | +2.3% | +5.6% |
| Mar 19 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.48 | $34.00 | -1.4% | -0.2% | -3.5% | -1.4% | +2.1% | +5.4% |
| Mar 18 | BTIG | Maintains | Buy → Buy | — | $35.23 | $35.02 | -0.6% | -2.1% | -2.3% | -5.5% | -3.5% | -0.1% |
| Mar 4 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.60 | $39.31 | +1.8% | +1.6% | -6.3% | -5.8% | -8.9% | -6.5% |
| Mar 4 | Cantor Fitzgerald | Maintains | Overweight → Overweight | — | $38.60 | $39.31 | +1.8% | +1.6% | -6.3% | -5.8% | -8.9% | -6.5% |
| Nov 12 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $38.74 | $38.58 | -0.4% | -0.8% | -2.2% | +5.3% | +4.0% | +2.6% |
| Nov 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $38.74 | $38.58 | -0.4% | -0.8% | -2.2% | +5.3% | +4.0% | +2.6% |
| Oct 1 | B. Riley Securities | Maintains | Buy → Buy | — | $48.18 | $48.03 | -0.3% | +0.4% | -0.9% | -5.7% | -12.5% | -13.0% |
| Sep 29 | Lake Street | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | +2.3% | +2.7% | +1.3% | -3.5% |
| Sep 29 | BTIG | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | +2.3% | +2.7% | +1.3% | -3.5% |
| Sep 29 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $47.10 | $49.54 | +5.2% | +2.8% | +2.3% | +2.7% | +1.3% | -3.5% |
| Sep 24 | BTIG | Maintains | Buy → Buy | — | $48.85 | $48.50 | -0.7% | -2.0% | -5.5% | -3.6% | -0.9% | -1.4% |
| Sep 23 | Craig-Hallum | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | +3.9% | +0.1% | +2.2% | +5.0% |
| Sep 23 | B. Riley Securities | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | +3.9% | +0.1% | +2.2% | +5.0% |
| Sep 23 | BTIG | Maintains | Buy → Buy | — | $46.09 | $47.33 | +2.7% | +6.0% | +3.9% | +0.1% | +2.2% | +5.0% |
| Aug 14 | BTIG | Maintains | Buy → Buy | — | $36.50 | $36.81 | +0.8% | +9.6% | +6.4% | +5.0% | +4.7% | +4.7% |
| Aug 13 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $34.83 | $35.98 | +3.3% | +4.8% | +14.9% | +11.5% | +10.0% | +9.8% |
| May 12 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $24.40 | $24.50 | +0.4% | +9.3% | +7.7% | +3.0% | +5.0% | +16.4% |
| Apr 1 | B. Riley Securities | Maintains | Buy → Buy | — | $26.60 | $26.25 | -1.3% | -6.1% | -2.1% | -9.5% | -11.6% | -13.2% |
| Mar 31 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $26.21 | $25.52 | -2.6% | +1.5% | -4.7% | -0.6% | -8.2% | -10.3% |
| Mar 18 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $23.32 | $28.93 | +24.1% | +15.7% | +17.0% | +20.5% | +21.8% | +28.6% |
| Oct 4 | Lake Street | Maintains | Buy → Buy | — | $49.75 | $50.94 | +2.4% | +1.2% | +1.8% | +2.5% | +2.5% | -0.2% |
| Oct 4 | Craig-Hallum | Maintains | Buy → Buy | — | $49.75 | $50.94 | +2.4% | +1.2% | +1.8% | +2.5% | +2.5% | -0.2% |
| Aug 29 | B. Riley Securities | Maintains | Buy → Buy | — | $39.56 | $39.94 | +1.0% | -0.8% | +2.3% | +0.2% | -0.7% | +1.2% |
| Aug 9 | Craig-Hallum | Maintains | Buy → Buy | — | $33.92 | $34.40 | +1.4% | +6.0% | +4.7% | +11.6% | +9.2% | +14.7% |
| Aug 9 | B. Riley Securities | Maintains | Buy → Buy | — | $33.92 | $34.40 | +1.4% | +6.0% | +4.7% | +11.6% | +9.2% | +14.7% |
| Jun 21 | Craig-Hallum | Maintains | Buy → Buy | — | $19.93 | $20.05 | +0.6% | +5.4% | +7.8% | +8.6% | +7.1% | +5.4% |
| Jun 3 | Lake Street | Maintains | Buy → Buy | — | $17.95 | $18.18 | +1.3% | -5.1% | -3.0% | -0.2% | +0.1% | +1.2% |
| May 15 | Craig-Hallum | Maintains | Buy → Buy | — | $16.24 | $16.56 | +2.0% | -1.9% | -0.5% | +3.2% | +3.4% | +1.5% |
| May 15 | B. Riley Securities | Maintains | Buy → Buy | — | $16.24 | $16.56 | +2.0% | -1.9% | -0.5% | +3.2% | +3.4% | +1.5% |
| Mar 22 | B. Riley Securities | Maintains | Buy → Buy | — | $10.58 | $10.58 | +0.0% | +8.7% | +13.4% | +18.9% | +20.3% | +25.0% |
| Jul 20 | B. Riley Securities | Maintains | Buy → Buy | — | $21.53 | $22.18 | +3.0% | -1.1% | +1.1% | -1.3% | -1.4% | -1.1% |
| Apr 17 | Lake Street | Maintains | Buy → Buy | — | $21.94 | $22.98 | +4.7% | +6.0% | +7.8% | +7.1% | +8.5% | +12.3% |
| May 20 | B. Riley Securities | Maintains | Buy → Buy | — | $5.77 | $5.91 | +2.4% | +2.3% | +19.4% | +6.6% | +12.7% | +18.2% |
| Jul 2 | Ladenburg Thalmann | Maintains | Buy → Buy | — | $9.09 | $9.53 | +4.8% | +1.2% | -5.2% | -6.9% | -5.8% | -7.3% |
| Apr 7 | B. Riley FBR | Maintains | Buy → Buy | — | $3.91 | $4.12 | +5.4% | +0.3% | +1.3% | +4.6% | +8.7% | +16.9% |
| Apr 7 | B. Riley Securities | Maintains | Buy → Buy | — | $3.91 | $4.12 | +5.4% | +0.3% | +1.3% | +4.6% | +8.7% | +16.9% |
| Mar 16 | B. Riley Securities | Maintains | Buy → Buy | — | $4.98 | $4.25 | -14.7% | -21.1% | -22.3% | -28.3% | -25.7% | -25.9% |
| Mar 16 | B. Riley FBR | Maintains | Buy → Buy | — | $4.98 | $4.25 | -14.7% | -21.1% | -22.3% | -28.3% | -25.7% | -25.9% |
| Dec 10 | Lake Street | Maintains | Buy → Buy | — | $4.94 | $4.94 | +0.0% | +9.9% | +20.4% | +23.7% | +20.4% | +18.0% |
| Nov 28 | Rodman & Renshaw | Maintains | Buy → Buy | — | $2.61 | $2.68 | +2.7% | +12.6% | +6.1% | +4.2% | -0.4% | -2.7% |
| Jul 23 | Sterne Agee CRT | Maintains | Buy → Buy | — | $8.47 | $8.50 | +0.4% | -0.5% | -3.4% | -4.4% | -4.1% | -7.6% |
| Dec 16 | Craig-Hallum | Maintains | Buy → Buy | — | $8.05 | $8.09 | +0.5% | +5.6% | +5.1% | +5.5% | +3.1% | -0.6% |
No insider trades available.
8-K · 1.01
!! High
Unknown — 8-K 1.01: Material Agreement
HROW signed a material agreement with BTIG (a major investment bank), likely indicating a capital raise, M&A advisory, or strategic partnership that could significantly impact the company's growth trajectory and stock valuation.
Mar 27
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
Harrow priced a confidential offering on March 24, 2026, likely raising capital that dilutes existing shareholders but provides cash for operations or growth investments.
Mar 24
8-K · 8.01
!! High
Unknown — 8-K 8.01: Material Event / Announcement
HROW abandoned a planned securities offering, eliminating dilution risk and signaling management's confidence in current valuation or preference to preserve shareholder equity.
Mar 24
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
HROW's Regulation FD disclosure suggests management communicated material information to investors outside normal channels, requiring public disclosure to prevent selective information advantage.
Mar 10
8-K · 7.01
! Medium
Harrow, Inc. -- 8-K 7.01: Regulation FD Disclosure
Harrow, Inc. disclosed an investor presentation for use at conferences and meetings, providing updated information about the company's business and strategy to potential investors.
Mar 2
8-K · 5.02
!!! Very High
Harrow, Inc. -- 8-K 5.02: Executive Change
Patrick W. Sullivan's appointment as Chief Commercial Officer at Harrow, Inc. strengthens the company's commercial leadership and may improve revenue growth and market positioning.
Feb 2
Data updated apr 25, 2026 2:02pm
· Source: massive.com